Current Vascular Pharmacology
Title:Editorial [Hot Topic: Current Antithrombotic Management of ST Elevation Acute Coronary Syndromes in the Cath Lab – A Paradigm Shift (Guest Editor: Bernardo Cortese)]
Volume: 10 Issue: 4
Author(s): Bernardo Cortese
Affiliation:
Export Options
About this article
Cite this article as:
Cortese Bernardo, Editorial [Hot Topic: Current Antithrombotic Management of ST Elevation Acute Coronary Syndromes in the Cath Lab – A Paradigm Shift (Guest Editor: Bernardo Cortese)], Current Vascular Pharmacology 2012; 10 (4) . https://dx.doi.org/10.2174/157016112800812791
DOI https://dx.doi.org/10.2174/157016112800812791 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Biotechnological Methods to Reduce Oxidative Stress in the Cardiovascular System: Focusing on the Bach1/Heme Oxygenase-1 Pathway
Current Pharmaceutical Biotechnology Does It Make Sense that Diabetes is Reciprocally Associated with Periodontal Disease?
Endocrine, Metabolic & Immune Disorders - Drug Targets Odontogenic Infections in the Etiology of Infective Endocarditis
Cardiovascular & Hematological Disorders-Drug Targets Fondaparinux for Management of Heparin-induced Thrombocytopenia after Cardiovascular Intervention: A Systematic Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Diagnosis of Surgically-Treatable Forms of Primary Aldosteronism
Current Hypertension Reviews Ginsenoside RB1 Reduces Neurologic Damage, is Anti-Apoptotic, and Down-Regulates p53 and BAX in Subarachnoid Hemorrhage
Current Neurovascular Research Immunomodulatory Properties of Antibiotics
Current Molecular Pharmacology Meet Our Editorial Board Member
Cardiovascular & Hematological Disorders-Drug Targets Antiplatelet Treatment in Stroke: New Insights
Current Pharmaceutical Design Gender Differences in the Effects of Angiotensin Receptor Blockers on Cardiovascular Disease
Current Pharmaceutical Design Cardioprotective effects of Aronia melanocarpa anthocynanins. From laboratory experiments to clinical practice.
Current Pharmaceutical Design Clinical Relevance of Non-Fasting and Postprandial Hypertriglyceridemia and Remnant Cholesterol
Current Vascular Pharmacology Ethnobotanical Treatment Strategies Against Alzheimers Disease
Current Alzheimer Research Sphingolipids in Cell Signaling: Their Function as Receptor Ligands, Second Messengers, and Raft Constituents
Current Immunology Reviews (Discontinued) Meet the Editorial Board
Letters in Drug Design & Discovery Emerging Molecular Targets for Imaging of Atherosclerotic Plaque using Positron Emission Tomography
Current Radiopharmaceuticals Retracted: Effects of Vitamin K2 on Osteoporosis
Current Pharmaceutical Design Crosstalk Between Calpain and Calcineurin in Excitotoxic Neurodegeneration; Therapeutic Targets for the Treatment of Excitotoxic Neurodegeneration
Current Medicinal Chemistry - Central Nervous System Agents Adenosine and Adenosine 5’-triphosphate Catabolism in Systemic Blood as a Potential Biomarker for Doxorubicin Cardiotoxicity in an Experimental Rat Model in vivo
Cardiovascular & Hematological Disorders-Drug Targets Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process
CNS & Neurological Disorders - Drug Targets